Inhibition of glucosylceramide accumulation results in effective blockade of polycystic kidney disease in mouse models-Reference-Cited by-同舟云学术

Inhibition of glucosylceramide accumulation results in effective blockade of polycystic kidney disease in mouse models

Published:2010-06-20 Issue:7 Volume:16 Page:788-792
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Natoli Thomas A,Smith Laurie A,Rogers Kelly A,Wang Bing,Komarnitsky Svetlana,Budman Yeva,Belenky Alexei,Bukanov Nikolay O,Dackowski William R,Husson Hervé,Russo Ryan J,Shayman James A,Ledbetter Steven R,Leonard John P,Ibraghimov-Beskrovnaya Oxana

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.2171.pdf

Reference40 articles.

1. Torres, V.E. & Harris, P.C. Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int. 76, 149–168 (2009).

2. Bukanov, N.O., Smith, L.A., Klinger, K.W., Ledbetter, S.R. & Ibraghimov-Beskrovnaya, O. Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine. Nature 444, 949–952 (2006).

3. Tao, Y., Kim, J., Schrier, R.W. & Edelstein, C.L. Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease. J. Am. Soc. Nephrol. 16, 46–51 (2005).

4. Leuenroth, S.J., Bencivenga, N., Chahboune, H., Hyder, F. & Crews, C.M. Triptolide reduces cyst formation in a neonatal to adult transition Pkd1 model of ADPKD. Nephrol. Dial Transplant. published online, doi:10.1093/ndt/gfp777 (4 February 2010).

5. Gattone, V.H. II, Wang, X., Harris, P.C. & Torres, V.E. Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist. Nat. Med. 9, 1323–1326 (2003).

Cited by 148 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucosylceramide synthase modulation ameliorates murine renal pathologies and promotes macrophage effector function in vitro;Communications Biology;2024-08-02

2. Investigational agents for autosomal dominant polycystic kidney disease: preclinical and early phase study insights;Expert Opinion on Investigational Drugs;2024-04-21

3. Glucosylceramide flippases contribute to cellular glucosylceramide homeostasis;Journal of Lipid Research;2024-03

4. Repurposing small molecules for nephronophthisis and related renal ciliopathies;Kidney International;2023-08

5. Impact of renal tubular Cpt1a overexpression on the kidney metabolome in the folic acid-induced fibrosis mouse model;Frontiers in Molecular Biosciences;2023-06-12